Word: systemics
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
...works under Kyoto, which simply exempts all CO2 emissions that come from using biofuels. CO2 emissions resulting from deforestation or other changes in the way we use land are not evaluated at all. The result is a huge, if accidental error in the existing global carbon accounting system - and one that now stands to be repeated in the cap-and-trade bill up for debate in Congress. "It's a very, very large loophole," says Searchinger, who had done pioneering work on problems of biofuels. "We're just effectively ignoring what happens on land." (See TIME's special report...
Given how limited the impact of the Kyoto Protocol has been, the effects of that error have been modest so far. But if the U.S. adopts a cap-and-trade system with the same mistake, or if the world agrees to a truly global successor to Kyoto, the blowback could be enormous. As long as biofuels are incorrectly treated as 100% carbon neutral, they'll represent an economical way for companies to offset their greenhouse-gas emissions and comply with a tightening carbon cap. One study estimates that if the world were to meet a 50% "cut" in global greenhouse...
...that may well be a boon. If cap-and-trade were passed with the existing biofuel loophole, it could set up a system that would incentivize the expansion of bioenergy at the expense of the environment and carbon cutting. Certainly the error could be fixed later, after the bill is passed - but by that time the financial interests in favor of biofuels would be even stronger, and would surely resist changes. "If this isn't fixed, you could give companies a very powerful financial incentive to go clear land," says Searchinger, who has briefed members of Congress on his research...
Undergraduate Council member George Hayward ’11 noted that the delivery of some text messages during the Kirkland shooting had been delayed—possibly because alerts had been sent to all subscribers at once, overloading the system...
...Waxman's loss that day was a big victory for drug companies, which have spent more than any other segment of the medical industry to make sure that they come out winners in the effort to overhaul the nation's health-care system. It's understandable the drugmakers would want a roll-call accounting of who their friends and enemies are, considering the size of the investment they are making on Capitol Hill: in the first six months of this year alone, drug and biotech companies and their trade associations spent more than $110 million - that's about...